Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma.

por Kazuma Ohyashiki, Tomohiro Umezu, Sei-Ichiro Yoshizawa, Yoshikazu Ito, Michiyo Ohyashiki, Hisashi Kawashima, Masami Tanaka, Masahiko Kuroda, Junko H Ohyashiki
Publicado 2011

Comprehensive analysis of liver and blood miRNA in precancerous conditions

por Tomohiro Umezu, Koichi Tsuneyama, Kohsuke Kanekura, Michiyo Hayakawa, Toshihito Tanahashi, Mitsuoki Kawano, Y-h Taguchi, Hidenori Toyoda, Akihiro Tamori, Masahiko Kuroda, Yoshiki Murakami
Publicado 2020

Author Correction: Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm

por Sho Kubota, Kenji Tokunaga, Tomohiro Umezu, Takako Yokomizo-Nakano, Yuqi Sun, Motohiko Oshima, Kar Tong Tan, Henry Yang, Akinori Kanai, Eisaku Iwanaga, Norio Asou, Takahiro Maeda, Naomi Nakagata, Atsushi Iwama, Kazuma Ohyashiki, Motomi Osato, Goro Sashida
Publicado 2019

Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm

por Sho Kubota, Kenji Tokunaga, Tomohiro Umezu, Takako Yokomizo-Nakano, Yuqi Sun, Motohiko Oshima, Kar Tong Tan, Henry Yang, Akinori Kanai, Eisaku Iwanaga, Norio Asou, Takahiro Maeda, Naomi Nakagata, Atsushi Iwama, Kazuma Ohyashiki, Motomi Osato, Goro Sashida
Publicado 2019